XML 37 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Summary of Revenue Significant Expenses and Net Loss for Segment

The following table presents revenue, significant expenses and net loss for the Company's segment (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Collaboration revenue

 

$

25

 

 

$

195

 

 

$

391

 

 

$

1,325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical related costs

 

 

90

 

 

 

2,186

 

 

 

2,722

 

 

 

13,204

 

Employee related costs

 

 

2,069

 

 

 

3,738

 

 

 

8,218

 

 

 

18,665

 

Product development and manufacturing costs

 

 

240

 

 

 

161

 

 

 

549

 

 

 

3,059

 

Facilities, support costs and depreciation

 

 

2,639

 

 

 

2,915

 

 

 

7,980

 

 

 

10,688

 

Professional, consulting and public company costs

 

 

1,245

 

 

 

833

 

 

 

3,564

 

 

 

6,676

 

Impairment of property and equipment

 

 

 

 

 

 

 

 

 

 

 

1,883

 

Impairment of right-of-use assets

 

 

 

 

 

 

 

 

 

 

 

22,836

 

Restructuring and other related charges

 

 

(21

)

 

 

2,804

 

 

 

1,262

 

 

 

9,254

 

Total operating expenses

 

 

6,262

 

 

 

12,637

 

 

 

24,295

 

 

 

86,265

 

Loss from operations

 

 

(6,237

)

 

 

(12,442

)

 

 

(23,904

)

 

 

(84,940

)

Other income:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

256

 

 

 

576

 

 

 

964

 

 

 

2,517

 

Other income

 

 

 

 

 

 

 

 

981

 

 

 

 

Total other income

 

 

256

 

 

 

576

 

 

 

1,945

 

 

 

2,517

 

Loss before income tax expense

 

 

(5,981

)

 

 

(11,866

)

 

 

(21,959

)

 

 

(82,423

)

Income tax expense

 

 

(3

)

 

 

(7

)

 

 

(9

)

 

 

(33

)

Net loss

 

$

(5,984

)

 

$

(11,873

)

 

$

(21,968

)

 

$

(82,456

)